Clinical trial
The Clinical Efficacy of Star Matrix Versus Autogenous Gingival Graft in Augmenting Keratinized Tissue Around Teeth- A Split-mouth Randomized Controlled Clinical Trial
NCT07440303 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Clinical Efficacy of Star Matrix Versus Autogenous Gingival Graft in Augmenting Keratinized Tissue Around Teeth- A Split-mouth Randomized Controlled Clinical Trial
- Lead sponsor
- Harvard Medical School (HMS and HSDM)
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 6, 2025
- Completion date
- October 1, 2026
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lack of keratinized gingiva, mucogingival deformity - insufficient keratinized tissue